Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $46.7000 (0.21%) ($45.3000 - $46.7000) on Wed. Sep. 23, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 50 | Latest Price | $46.7000(0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) XLF(7%) EWI(6%) IVE(6%) IWD(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.985% in a week (0% probabilities). VIXM(-4%) TLT(-4%) GLD(-3%) BND(-3%) VCSH(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $44.68(4.52%) | 10 Day Moving Average | $43.07(8.43%) | 20 Day Moving Average | $43.33(7.78%) | To recent high | -12.9% | To recent low | 21% | Market Cap | $920m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |